Morningside Venture Investments Limited 13D and 13G filings for Apellis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:05 pm Purchase |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Morningside Venture Investments Limited | 12,806,342 13.200% |
250,000 (+1.99%) |
Filing |
| 2021-02-16 4:17 pm Purchase |
2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Morningside Venture Investments Limited | 12,556,342 15.800% |
540,540 (+4.50%) |
Filing |